NeLM news service
DigiFab™ receives first European regulatory approval in Switzerland

Source: BioSpace

Date published: 05/02/2010 16:10

Summary
by: Yuet Wan

DigiFab™, the antidote for the treatment of patients with life-threatening digitalis intoxication, has been approved in Switzerland. The treatment is currently under review by the MHRA.

Preview your comment

Add new comment

Comment text:

Comments

There are no comments yet. You could be the first! You must be Logged In to comment.